Hebei Niuanmei Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hebei Niuanmei Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include NEWANGIE and BOMEITONG. The owner is based in Xingtai, Hebei.

Rm. 1505, Unit 1, 15F, Bldg. 3, Zijing

Guandi, #55 Quannan East St., Qiaodong,

Xingtai, Hebei 054000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOMEITONG
BOMEITONG
Registered 2023
NEWANGIE
NEWANGIE
Registered 2023

Trademark Classifications

Hebei Niuanmei Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hebei Niuanmei Technology Co., Ltd. have?

Hebei Niuanmei Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Hebei Niuanmei Technology Co., Ltd. file in?

Hebei Niuanmei Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Hebei Niuanmei Technology Co., Ltd.'s most well-known trademarks?

Hebei Niuanmei Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEWANGIE and BOMEITONG. These are among 2 currently registered trademarks in the portfolio.

What is Hebei Niuanmei Technology Co., Ltd.'s trademark registration success rate?

Hebei Niuanmei Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.